Patent Assignment
Reel/Frame 075642/0639
Supplemental Confirmatory Grant of Security Interest in United States Patents
Recorded: 2026-05-18
Pages: 11
Assignor
HARMONY BIOSCIENCES MANAGEMENT, INC. (F/K/A ZYNERBA PHARMACEUTICALS, INC.)
Executed: 2026-05-04
Assignee
JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
WLS - DOCUMENT WORKFLOW MANAGEMENT 10 SOUTH DEARBORN STREET - FLOOR L2, MAIL CODE IL1-1190, CHICAGO, ILLINOIS, 60603
Covered Properties
(46)
Therapeutic Combinations of Drugs and Methods of Using Them
Application:
17/860,539 →
Publication:
US US20230002377A1
Method of Treating Symptoms of Prader-Willi Syndrome
Application:
18/679,624 →
Publication:
US US20240398777A1
Treatment of 22Q11.2 Deletion Syndrome with Cannabidiol
Treatment of 22Q11.2 Deletion Syndrome with Cannabidiol
Application:
18/970,458 →
Publication:
US US20250205174A1
Treatment of Autism with Cannabidiol
Application:
19/008,407 →
Publication:
US US20250134832A1
Treatment of Fragile X Syndrome with Cannabidiol
Application:
19/011,503 →
Publication:
US US20250134833A1
Synthetic Transdermal Cannabidiol for the Treatment of Focal Epilepsy in Adults
Application:
18/765,056 →
Publication:
US US20250213465A1
Treatment of 22Q112 Deletion Syndrome with Cannabidiol
Application:
17/942,068 →
Publication:
US US20230000793A1
Cannabidiol for the Treatment of Refractory Seizures
Application:
18/255,816 →
Publication:
US US20240009210A1
Treatment of Sleep Apnea with Cbd
Application:
18/263,092 →
Publication:
US US20240307418A1
Treatment of Irritability in Subjects with Autism Spectrum Disorders with Moderate to Severe Anxiety and/or Social Avoidance
Application:
18/642,059 →
Publication:
US US20240342198A1
Methods of Treatment of Osteoarthritis with Transdermal Cannabidiol Gel
Application:
19/007,534 →
Publication:
US US20250268843A1
Prodrugs of Tetrahydrocannabinol Compositions Comprising Prodrugs of Tetrahydrocannabinol and Methods of Using the Same
Application:
19/035,515 →
Publication:
US US20260008763A1
Synthetic Transdermal Cannabidiol for the Treatment of Focal Epilepsy in Adults
Application:
19/039,288 →
Publication:
US US20250302734A1
Treatment of Fragile X Syndrome with Cannabidiol
Application:
19/047,231 →
Publication:
US US20250177322A1
Treatment of Fragile X Syndrome with Cannabidiol
Application:
19/350,112 →
Publication:
US US20260027137A1
Treatment of Fragile X Syndrome and Autism Spectrum Disorder with Cannabidiol
Application:
19/355,273 →
Publication:
US US20260034151A1
Treatment of Behavioral Impairment in Developmental and Epileptic Encephalopathy
Application:
19/399,173 →
Publication:
US US20260076984A1
Treatment of SYNGAP1 Encephalopathy
Application:
19/403,384 →
Publication:
US US20260083758A1
Azinone-Substituted Azepino[B]Indole and Pyrido-Pyrrolo-Azepine Mch-1 Antagonists, Methods of Making, and Use Thereof
(1-Azinone)-Substituted Pyridoindoles
(1-Azinone)-Substituted Pyridoindoles
Treatment of 22Q11.2 Deletion Syndrome with Cannabidiol
Treatment of Autism with Cannabidiol
Treatment of Fragile X Syndrome with Cannabidiol
Treatment of Behavioral Impairment in Developmental and Epileptic Encephalopathy
Treatment of Fragile X Syndrome with Cannabidiol
(1-Azinone)-Substituted Pyridoindoles
Transdermally Deliverable Opioid Prodrugs, Abuse-Resistant Compositions and Methods of Using Opioid Prodrugs
Prodrugs of Tetrahydrocannabinol, Compositions Comprising Prodrugs of Tetrahydrocannabinol and Methods of Using the Same
Transdermally Deliverable Opioid Prodrugs, Abuse-Resistant Compositions and Methods of Using Opioid Prodrugs
Prodrugs of Tetrahydrocannabinol, Compositions Comprising Prodrugs of Tetrahydrocannabinol and Methods of Using the Same
Prodrugs of Cannabidiol, Compositions Comprising Prodrugs of Cannabidiol and Methods of Using the Same
Transdermal Delivery of Cannabidiol
Transdermal Delivery of Cannabidiol
Prodrugs of Tetrahydrocannabinol, Compositions Comprising Prodrugs of Tetrahydrocannabinol and Methods of Using the Same
Prodrugs of Tetrahydrocannabinol, Compositions Comprising Prodrugs of Tetrahydrocannabinol and Methods of Using the Same
Treatment of Fragile X Syndrome with Cannabidiol
Patent:
10,213,390 →
Application:
16/144,632 →
Treatment of Autism with Cannabidiol
Treatment of Fragile X Syndrome with Cannabidiol
Treatment of Autism with Cannabidiol
Treatment of Fragile X Syndrome with Cannabidiol
Treatment of 22Q11.2 Deletion Syndrome with Cannabidiol
Treatment of Fragile X Syndrome with Cannabidiol
Treatment of Fragile X Syndrome with Cannabidiol
Use of Cannabidiol Prodrugs in Pharmaceutical Compositions
Patent:
47,885 →
Application:
16/219,285 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Release of Security Interest
Jul 9, 2014
From: WELLS FARGO
To: ALBANY MOLECULAR RESEARCH, INC.
Reel/Frame 033283/0357 →
Security Interest
Oct 24, 2014
From: ALBANY MOLECULAR RESEARCH, INC.; ALO ACQUISITION LLC; AMRI BURLINGTON, INC.; AMRI RENSSELAER, INC.
To: BARCLAYS BANK PLC, AS THE COLLATERAL AGENT
Reel/Frame 034045/0951 →
Release of Security Interest
Aug 31, 2017
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: ALBANY MOLECULAR RESEARCH, INC.; ALO ACQUISITION LLC; AMRI BURLINGTON, INC.; AMRI RENSSELAER, INC.
Reel/Frame 043742/0085 →
Second Lien Security Agreement
Sep 1, 2017
From: ALBANY MOLECULAR RESEARCH, INC.; AMRI BURLINGTON, INC.; CEDARBURG PHARMACEUTICALS, INC.; EUTICALS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 043746/0657 →
First Lien Security Agreement
Sep 1, 2017
From: ALBANY MOLECULAR RESEARCH, INC.; AMRI BURLINGTON, INC.; CEDARBURG PHARMACEUTICALS, INC.; EUTICALS INC.
To: BARCLAYS BANK, PLC AS COLLATERAL AGENT
Reel/Frame 043746/0621 →
Corrective Assignment to Correct the Incorrect Patent No. 7541537 Previously Recorded at Reel: 034045 Frame: 0951. Assignor(S) Hereby Confirms the Security Interest.
Aug 14, 2018
From: ALBANY MOLECULAR RESEARCH, INC.; ALO ACQUISITION LLC; AMRI BURLINGTON, INC.; AMRI RENSSELAER, INC.
To: BARCLAYS BANK PLC, AS THE COLLATERAL AGENT
Reel/Frame 046796/0352 →
Release of Security Interest
Oct 29, 2020
From: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT
To: ALBANY MOLECULAR RESEARCH, INC.; AMRI BURLINGTON, INC.; CEDARBURG PHARMACEUTICALS, INC.; EUTICALS INC.
Reel/Frame 054252/0687 →
Security Interest
Aug 9, 2021
From: HARMONY BIOSCIENCES, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 057120/0282 →
Assignment of Assignor's Interest
Aug 12, 2021
From: CURIA GLOBAL, INC. (F/K/A ALBANY MOLECULAR RESEARCH, INC.)
To: HARMONY BIOSCIENCES, LLC
Reel/Frame 057163/0620 →
Assignment of Assignor's Interest
Aug 12, 2021
From: CURIA GLOBAL, INC. (F/K/A ALBANY MOLECULAR RESEARCH, INC.)
To: HARMONY BIOSCIENCES, LLC
Reel/Frame 057163/0596 →
Assignment of Assignor's Interest
Jan 20, 2023
From: CONSYNANCE THERAPEUTICS, INC.
To: HARMONY BIOSCIENCES, LLC
Reel/Frame 062434/0318 →
Assignment of Assignor's Interest
Jan 20, 2023
From: LIU, SHUANG; MAKI, JOHN; GUZZO, PETER R.; CUI, WENGE
To: CONSYNANCE THERAPEUTICS, INC.
Reel/Frame 062434/0465 →
Assignment of Assignor's Interest
Jul 26, 2023
From: GUZZO, PETER ROBERT; SURMAN, MATTHEW DAVID; HENDERSON, ALAN JOHN; JIANG, MAY XIAOWU
To: ALBANY MOLECULAR RESEARCH, INC.
Reel/Frame 064391/0348 →
Supplemental Confirmatory Grant of Security Interest in United States Patents
Jul 27, 2023
From: HARMONY BIOSCIENCES, LLC
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 064417/0852 →
Change of Name
Apr 22, 2024
From: ALBANY MOLECULAR RESEARCH, INC.
To: CURIA GLOBAL, INC.
Reel/Frame 067186/0720 →
Assignment of Assignor's Interest
Jun 5, 2024
From: BUDUR, KUMARASWAMY; RAPCHAK, KRYSTLE DAVIS; DAYNO, JEFFREY MARC; BAUER, ERIC DAVID
To: HARMONY BIOSCIENCES, LLC
Reel/Frame 067630/0276 →
Assignment of Assignor's Interest
Jun 24, 2024
From: BUDUR, KUMARASWAMY; RAPCHAK, KRYSTLE DAVIS; DAYNO, JEFFREY MARC; BAUER, ERIC DAVID
To: HARMONY BIOSCIENCES, LLC
Reel/Frame 067812/0218 →
Change of Name
Oct 23, 2024
From: ALBANY MOLECULAR RESEARCH, INC.
To: CURIA GLOBAL, INC.
Reel/Frame 069231/0127 →
Assignment of Assignor's Interest
Oct 29, 2024
From: HARMONY BIOSCIENCES, LLC
To: HARMONY BIOSCIENCES MANAGEMENT, INC.
Reel/Frame 069051/0154 →
Assignment of Assignor's Interest
Nov 4, 2024
From: HARMONY BIOSCIENCES, LLC
To: HARMONY BIOSCIENCES MANAGEMENT, INC.
Reel/Frame 069126/0975 →
Assignment of Assignor's Interest
Nov 13, 2024
From: HARMONY BIOSCIENCES, LLC
To: HARMONY BIOSCIENCES MANAGEMENT, INC.
Reel/Frame 069248/0274 →
Change of Name
Nov 13, 2024
From: ALBANY MOLECULAR RESEARCH, INC.
To: CURIA GLOBAL, INC.
Reel/Frame 069354/0851 →
Assignment of Assignor's Interest
Nov 18, 2024
From: HARMONY BIOSCIENCES, LLC
To: HARMONY BIOSCIENCES MANAGEMENT, INC.
Reel/Frame 069297/0828 →
Change of Name
Nov 21, 2024
From: ZYNERBA PHARMACEUTICALS, INC.
To: HARMONY BIOSCIENCES MANAGEMENT, INC.
Reel/Frame 069432/0319 →
Assignment of Assignor's Interest
Nov 21, 2024
From: SEBREE, TERRI; GUTTERMAN, DONNA
To: ZYNERBA PHARMACEUTICALS, INC.
Reel/Frame 069432/0223 →